| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| F2 |
(2S)-N-[(3-chlorophenyl)methyl]-1-(2-cyclohexylethyl)pyrrolidine-2-carboxamide |
370000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(2S)-N-[(3-chlorophenyl)methyl]-1-(3-phenylpropyl)pyrrolidine-2-carboxamide |
550000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(2S)-1-[(2R)-2-aminopropyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide;hydrochloride |
512000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(2S)-1-[(2R)-2-aminobutyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide;hydrochloride |
430000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(2S)-1-[(2R)-2-amino-3-methylbutyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide;hydrochloride |
370000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(2S)-1-[(2R)-2-amino-4-methylpentyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide;hydrochloride |
136000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(R)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1-imino-ethyl)-pyrrolidin-3-yloxy]-phenyl}-propionic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
Pentasodium;[4-[3-[8-[4-[[2-(3,4-disulfonatooxyphenyl)-4-oxo-3,7-disulfonatooxychromen-5-yl]oxymethyl]triazol-1-yl]octyl]-4-oxoquinazolin-2-yl]phenyl] sulfate |
NA |
500000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
3-(Phenylmethyl)benzenecarboximidamide |
398107.17 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
3-Nitrobenzamidinium hydrochloride |
2511886.43 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-29-(4-aminobutyl)-11,23-dibenzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-17-methyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-11,23-dibenzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-17,29-dimethyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-23-benzyl-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-26-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-17,29-dimethyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(3R,8R,11S,14S,17S,20S,23S,26S,29S,32S)-3-amino-20-[(1-carbamimidoylpiperidin-4-yl)methyl]-11-(carboxymethyl)-23-(hydroxymethyl)-17,26-bis[(4-hydroxyphenyl)methyl]-29-methyl-14-(2-methylpropyl)-2,10,13,16,19,22,25,28,31-nonaoxo-5,6-dithia-1,9,12,15,18,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-8-carboxylic acid |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| F2 |
4-(4-Guanidinobenzoyloxy)phenylacetate |
NA |
107500 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
N-[(6-amino-2-methylpyridin-3-yl)methyl]-1-[[4-(pyrazol-1-ylmethyl)phenyl]methyl]pyrazole-4-carboxamide |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(12E)-20-amino-22-methyl-6-(pyrazol-1-ylmethyl)-9,17-dioxa-1,21,25,29-tetrazatetracyclo[25.2.1.03,8.018,23]triaconta-3(8),4,6,12,18,20,22,27(30),28-nonaen-26-one |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
ASGPR modulator-1 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
20-Amino-22-methyl-6-(pyrazol-1-ylmethyl)-9,17-dioxa-1,21,25,29-tetrazatetracyclo[25.2.1.03,8.018,23]triaconta-3(8),4,6,13,18,20,22,27(30),28-nonaen-26-one |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| F2 |
(8e)-3-Amino-1-Methyl-15-[(1h-Pyrazol-1-Yl)methyl]-7,10,11,12,24,25-Hexahydro-6h,18h,23h-19,22-(Metheno)pyrido[4,3-J][1,9,13,17,18]benzodioxatriazacyclohenicosin-23-One |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |